Status:
COMPLETED
Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
Lead Sponsor:
Puma Biotechnology, Inc.
Conditions:
Breast Cancer
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men or women of nonchildbearing potential,
- 18-50 years old.
- Healthy as determined by the investigator, including physical examination, laboratory test results, and medical history.
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00708903
Start Date
May 1 2008
End Date
July 1 2008
Last Update
May 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tacoma, Washington, United States, 98418